FDA warns Bio-Botanica/Nature’s Answer that Coral Calcium supplement is adulterated because it contains cesium chloride without required new dietary ingredient notification or safety evidence.
What happened
The warning letter concerns Coral Calcium, labeled as a dietary supplement, whose labeling declares cesium chloride as a dietary ingredient. The letter does not cite an inspection, website review, or import sample. FDA says cesium chloride is a new dietary ingredient not shown to be marketed before October 15, 1994; no required new dietary ingredient notification was submitted, and FDA says there is no safety evidence, with animal and human reports of serious heart problems.
What FDA found
Coral Calcium contains cesium chloride, a new dietary ingredient (an ingredient not marketed in the U.S. before October 15, 1994), without the required premarket notification to FDA.
section 413(a)(2) of the Act [21 U.S.C. § 350b(a)(2)] and 21 CFR 190.6FDA says there is no information that cesium chloride was lawfully marketed as a dietary ingredient before October 15, 1994, or was present in the food supply without chemical alteration.
section 413(d) of the Act [21 U.S.C. § 350b(d)]Even if a new dietary ingredient notification had been submitted, FDA says there is no history of use or other evidence showing cesium chloride is safe as a dietary ingredient.
sections 402(f) and 413(a) of the Act [21 U.S.C. §§ 342(f) and 350b(a)]FDA says cesium chloride can cause irregular heartbeats and low potassium, and there are reports of serious heart problems in humans, so the supplement is adulterated.
section 402(f)(1)(B) of the Act [21 U.S.C. § 342(f)(1)(B)]FDA says introducing the product into interstate commerce is prohibited.
sections 301(a) and (v) of the Act [21 U.S.C. § 331(a) and (v)]
What FDA wants
FDA tells the company to notify it in writing within 15 working days of the specific steps taken to address the violations, including an explanation of steps to prevent recurrence and copies of related documentation. If corrective actions cannot be completed within 15 working days, the company must state the reason for the delay and the time within which it will do so.
Who should pay attention
- retailers selling Coral Calcium or cesium chloride supplements
- brands and distributors of dietary supplements with novel ingredients
- quality teams handling new dietary ingredient notifications
This is a summary. Read the original letter on fda.gov.